David Hung is the founder of Nuvation Bio. Nuvation Bio has raised $275M in total funding. Latest round: Series A. Based in New York, NY, United States.
David Hung, M.D. is the Founder, President, and Chief Executive Officer of Nuvation Bio, an oncology-focused biotechnology company. The company closed a $275 million Series A financing round in October 2019, led by Omega Funds. Prior to Nuvation Bio, Dr. Hung founded and served as President and Chief Executive Officer of Medivation, Inc., which was acquired by Pfizer, Inc. for $14.3 billion in 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library